Corey N. Fishman - Mar 11, 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Chief Executive Officer, Director
Signature
/s/ Corey N. Fishman
Stock symbol
ITRM
Transactions as of
Mar 11, 2022
Transactions value $
$0
Form type
4
Date filed
3/15/2022, 05:00 PM
Previous filing
Jun 25, 2021
Next filing
Mar 14, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Options Exercise +215K +66.77% 537K Mar 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Options Exercise $0 -215K -50% $0.00 215K Mar 11, 2022 Ordinary Shares 215K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2 On March 11, 2021, the reporting person was granted an award of 430,000 RSUs, 50% of which vested on March 11, 2022.